4//SEC Filing
Newman James W. Jr. 4
Accession 0001213900-21-008165
CIK 0001513525other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:54 PM ET
Size
5.5 KB
Accession
0001213900-21-008165
Insider Transaction Report
Form 4
Newman James W. Jr.
Director
Transactions
- Award
Stock Option
2021-02-08+40,000→ 40,000 totalExercise: $3.11From: 2021-03-08Exp: 2031-02-07→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718364
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:54 PM ET
- Size
- 5.5 KB